Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience
Ava Diarra(Centre Hospitalier de Tourcoing), Louis Terriou(Centre Hospitalier Universitaire de Lille), Claude Preudhomme(Centre Hospitalier Universitaire de Lille), É. Hachulla(Centre Hospitalier Universitaire de Lille), Valérie Coiteux(Hôpital Claude Huriez), Quentin Scanvion(Inserm), Pierre Sujobert(Université Claude Bernard Lyon 1), Fiorenza Barraco(Hôpital Lyon Sud), Ibrahim Yakoub‐Agha(Inserm), Élise Fournier(Inserm), Bruno Quesnel(Université de Lille), Nicolas Duployez(Inserm), Marie Balsat(Hospices Civils de Lyon), Maël Heiblig(Université Claude Bernard Lyon 1), Léonardo Magro(Inserm), David Launay(Inserm)
Cited by 146
Related Papers
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2018|1k
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
|New England Journal of Medicine|2009|857